Related Topics News -

     
 Detail   |   Print    Next page > 
     
《業績》邁博藥業全年純利5,713萬人民幣 虧轉盈
2026-03-26T  
《業績》邁博藥業中期純利290萬人民幣 虧轉盈
2025-08-29T  
《業績》邁博藥業全年虧損收窄至1.28億元人民幣
2025-03-27T  
邁博藥業核心產品CMAB008獲巴基斯坦註冊批准
2025-01-02T  
邁博藥業核心產品CMAB008獲印尼上市許可
2024-12-29T  
《業績》邁博藥業中期虧損收窄至9,757萬人民幣
2024-08-29T  
邁博藥業核心產品CMAB008獲秘魯上市註冊申請
2024-07-03T  
先聲藥業合作注射液產品「恩立妥」獲批內地上市
2024-06-25T  
邁博藥業:恩立妥獲國家藥監局批准上市
2024-06-25T  
《公司業績》邁博藥業全年虧損收窄至2.09億人民幣
2024-03-27T  
  Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.